Betamethasone Dipropionate Salicylic Acid — brands & medicines in Pakistan
Pakistan mein Betamethasone Dipropionate Salicylic Acid ke 1 brands available hain. Drug class: Topical Corticosteroid. Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Betamethasone Dipropionate Salicylic Acid is a topical corticosteroid used in Pakistan for Psoriasis, Eczema (ekzima), Seborrheic dermatitis (seborreic dermatitis). Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Betamethasone Dipropionate Salicylic Acid?
Betamethasone Dipropionate Salicylic Acid is a topical corticosteroid used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Betamethasone Dipropionate Salicylic Acid under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Psoriasis
- Eczema (ekzima)
- Seborrheic dermatitis (seborreic dermatitis)
- Contact dermatitis
- Lichen planus
- Lichen simplex
- Other inflammatory skin conditions with scaling (any other inflammatory skin condition with scaling)
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed
This is a general adult guidance pattern based on the manufacturer's label for one of the Betamethasone Dipropionate Salicylic Acid brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Burning or stinging at application site
- Itching
- Dryness
Serious — stop and see a doctor
- Severe skin irritation
- Redness and swelling
- Breathing issue
Important warnings
- Don't use Betasalic Ointment if you are allergic to its ingredients
- Avoid using during skin infections
Drug class
CorticosteroidsBetamethasone Dipropionate Salicylic Acid brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Betamethasone Dipropionate Salicylic Acid used for in Pakistan?
Betamethasone Dipropionate Salicylic Acid is commonly used for Psoriasis, Eczema (ekzima), Seborrheic dermatitis (seborreic dermatitis), Contact dermatitis, and other indications. It belongs to the topical corticosteroid drug class.
What is the typical dosage of Betamethasone Dipropionate Salicylic Acid?
Typical adult dosing is described by manufacturers as: "As prescribed". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Betamethasone Dipropionate Salicylic Acid?
Common side effects include Burning or stinging at application site, Itching, Dryness. Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Betamethasone Dipropionate Salicylic Acid and see a doctor?
Stop Betamethasone Dipropionate Salicylic Acid and seek urgent medical care if you experience: Severe skin irritation; Redness and swelling; Breathing issue. These are serious signs that need immediate attention.
Is Betamethasone Dipropionate Salicylic Acid available without a prescription in Pakistan?
Prescription required.
What brands of Betamethasone Dipropionate Salicylic Acid are available in Pakistan?
1 brand of Betamethasone Dipropionate Salicylic Acid is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization